PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 50 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $114,000 | -94.4% | 86,000 | -89.1% | 0.00% | – |
| Q4 2021 | $2,054,000 | +186.1% | 786,400 | +240.6% | 0.00% | – |
| Q3 2021 | $718,000 | +187.2% | 230,859 | +243.1% | 0.00% | – |
| Q2 2021 | $250,000 | -53.8% | 67,284 | -56.9% | 0.00% | – |
| Q1 2021 | $541,000 | -1.3% | 156,285 | -4.1% | 0.00% | – |
| Q4 2020 | $548,000 | +426.9% | 162,978 | +449.6% | 0.00% | – |
| Q3 2020 | $104,000 | -8.0% | 29,653 | +20.9% | 0.00% | – |
| Q2 2020 | $113,000 | -72.2% | 24,529 | -42.7% | 0.00% | – |
| Q1 2019 | $407,000 | – | 42,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,400,000 | 0.70% |
| NEA Management Company, LLC | 6,643,704 | $22,323,000 | 0.59% |
| DAFNA Capital Management LLC | 320,542 | $1,077,000 | 0.32% |
| Platform Technology Partners | 141,025 | $474,000 | 0.23% |
| Parkman Healthcare Partners LLC | 110,547 | $371,000 | 0.10% |
| Rock Springs Capital Management LP | 1,314,374 | $4,416,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 140,341 | $472,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 65,000 | $218,000 | 0.04% |
| Virtu Financial LLC | 28,821 | $97,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,600 | $429,000 | 0.01% |